Kelly Fischer, MSN, FNP-BC, and Sarah Fischer, NP, of @danafarber.bsky.social detailed their overall impressions and takeaways to Oncology Nursing News after presenting “Antibody-Drug Conjugates in Breast Cancer” at #JADPROLive2026.
➡️bit.ly/4igQh5C
➡️bit.ly/4igQh5C
JADPRO Live 2026 Takeaways for Oncology Nurses and APPs | Oncology Nursing News
Dana-Farber nurse practitioners reflect on cross-country networking, resource gaps, and ADC education needs after JADPRO Live 2026.
bit.ly
October 29, 2026 at 6:30 PM
Kelly Fischer, MSN, FNP-BC, and Sarah Fischer, NP, of @danafarber.bsky.social detailed their overall impressions and takeaways to Oncology Nursing News after presenting “Antibody-Drug Conjugates in Breast Cancer” at #JADPROLive2026.
➡️bit.ly/4igQh5C
➡️bit.ly/4igQh5C
Kelly Fischer, MSN, FNP-BC, and Sarah Fischer, NP, of @danafarber.bsky.social shared from #JADPROLive2026 how their team selects patients for ADCs and monitors for lung, nerve, and heart toxicity. #BreastCancerAwareness
Read more in Oncology Nursing News: bit.ly/4iatkCr
Read more in Oncology Nursing News: bit.ly/4iatkCr
What Oncology Nurses Need to Know About ADCs in Breast Cancer | Oncology Nursing News
Dana-Farber nurse practitioners outline ADC patient selection, sequencing, ILD surveillance, and patient education from JADPRO Live 2026.
bit.ly
October 28, 2026 at 6:30 PM
Kelly Fischer, MSN, FNP-BC, and Sarah Fischer, NP, of @danafarber.bsky.social shared from #JADPROLive2026 how their team selects patients for ADCs and monitors for lung, nerve, and heart toxicity. #BreastCancerAwareness
Read more in Oncology Nursing News: bit.ly/4iatkCr
Read more in Oncology Nursing News: bit.ly/4iatkCr